Patents Examined by Audrea B Coniglio
  • Patent number: 10799438
    Abstract: A solid hair conditioner composition includes (i) a hair conditioner concentrate; and (ii) a carbon dioxide effervescing system including a salt of carbonic acid and an acidifying agent.
    Type: Grant
    Filed: April 21, 2016
    Date of Patent: October 13, 2020
    Assignee: COSMETIC WARRIORS LIMITED
    Inventors: Mark Constantine, Margaret Joan Constantine, Helen Elizabeth Ambrosen, Rowena Jacqueline Bird, Daniel James Campbell
  • Patent number: 10780046
    Abstract: Topical vaginal compositions are disclosed herein which include silica microspheres and an active ingredient in the amount of 0.001 to 15.0% w/w selected from estradiol, metronidazole, clindamycin, butoconazole, and combinations thereof. The topical compositions provide sustained release of the active ingredient so as to reduce skin irritation.
    Type: Grant
    Filed: April 17, 2019
    Date of Patent: September 22, 2020
    Assignee: SOL-GEL TECHNOLOGIES LTD.
    Inventors: Marina Shevachman, Amira Ze'Evi, Eilon Asculai, Batella Binyaminovich, Nir Avram, Chaim Aschkenasy
  • Patent number: 10779531
    Abstract: Provided is an insect repellent having excellent repellent activity and being highly safe. An insect repellent comprising, as an active ingredient, at least one compound selected from the group consisting of octahydro-7-methyl-1,4-methanonaphthalen-6(2H)-one, 3-methyl-5-propyl-2-cyclohexen-1-one, octahydro-5-methoxy-4,7-methane-1H-indene-2-carboxaldehyde, 6-methylquinoline, phenoxyacetaldehyde, ?-octalactone, 9-ethylidene-3-oxatricyclo(6.2.1.02,7)undecan-4-one, 2,3,3-trimethyl-2H-inden-1-one, 4-methyl-5-thiazoleethanol, 7-methoxy-3,7-dimethyloctanal, 3-methyl-1-phenyl-3-pentanol, 2-phenylpropionaldehyde dimethyl acetal, octahydro-2H-1-benzopyran-2-one and 2,6,6-trimethylcyclohexa-1,3-diene-1-carbaldehyde.
    Type: Grant
    Filed: February 23, 2016
    Date of Patent: September 22, 2020
    Assignee: Kao Corporation
    Inventors: Takao Nakagawa, Kouhei Takeuchi, Ryouta Koizumi
  • Patent number: 10765686
    Abstract: The present invention relates to a stable fixed dose aqueous pharmaceutical composition (e.g., contained in a container) for nasal administration to a human, comprising mometasone or its salt, olopatadine or its salt. The composition may further include a hydrocolloid. The invention also relates to a process for preparing the pharmaceutical composition, and the use of the pharmaceutical composition in the treatment of rhinitis in a subject.
    Type: Grant
    Filed: September 13, 2017
    Date of Patent: September 8, 2020
    Assignee: GLENMARK SPECIALTY S.A.
    Inventors: Ulhas R. Dhuppad, Ashok Katkurwar, Yashwant Gupta, Rajesh Ankam, Chandrakant Dhatrak
  • Patent number: 10768168
    Abstract: Provided herein are screening methods for identifying compounds for use as an arthropod repellent based on the masking or inhibition of the detection of the skin odor by a cpA neuron. Provided herein are also screening methods for identifying compounds for use as an arthropod attractant based on activation of the cpA neuron. Further provided are one or more compounds identified using the screening methods described herein, and compositions containing such compounds.
    Type: Grant
    Filed: December 21, 2017
    Date of Patent: September 8, 2020
    Assignee: The Regents of the University of California
    Inventors: Anandasankar Ray, Sean Michael Boyle, Dyan MacWilliam, Genevieve Mitchell Tauxe
  • Patent number: 10744227
    Abstract: Hydrogels comprising a macromolecular matrix and water may be used to augment soft tissue of a human being, promote or support cell or tissue viability or proliferation, create space in tissue, and for other purposes. A macromolecular matrix may comprise a hyaluronic acid component crosslinked to a silk fibroin component.
    Type: Grant
    Filed: May 1, 2019
    Date of Patent: August 18, 2020
    Assignee: ALLERGAN, INC.
    Inventors: Xiaojie Yu, Darin J. Messina, Elizabeta Pavlovic, Cunqi Cui, Kate M. Smither
  • Patent number: 10744235
    Abstract: A degradable, removable, pharmaceutical implant for the sustained release of one or more drugs in a subject, wherein the pharmaceutical implant is composed of a tube comprising an outer wall made of a degradable polymer completely surrounding a cavity, wherein the outer wall has a plurality of openings and wherein the cavity contains one or more sets of micro-particles, which micro-particles contain an active agent or a combination of two or more active agents, and wherein the size of the microparticles is selected such that the majority of the microparticles cannot pass through the openings.
    Type: Grant
    Filed: June 10, 2014
    Date of Patent: August 18, 2020
    Assignee: Janssen Sciences Ireland Unlimited Company
    Inventors: Lieven Elvire Colette Baert, Iksoo Chun, Guenter Kraus, Deborah M. Schachter, Qiang Zhang
  • Patent number: 10736826
    Abstract: Creamy cleansing compositions and creamy compositions which contain (A) at least one component selected from the group consisting of N-acyl acidic amino acid and a salt thereof, and N-acyl neutral amino acid and a salt thereof, (B) at least one polyhydric alcohol, (C) at least one N-mono middle-chain acyl basic amino acid or a salt thereof, and (D) water have good creamy appearance with high grade pearly gloss, are superior in form stability, and superior in the sense of use such as cream elongation, water miscibility, and the like.
    Type: Grant
    Filed: January 4, 2019
    Date of Patent: August 11, 2020
    Assignee: AJINOMOTO CO., INC.
    Inventors: Takahiro Suzuki, Kazuhiko Tobita
  • Patent number: 10729783
    Abstract: The present invention relates to hollow silica nanoparticles as a drug delivery system loading bioactive ingredients. Particularly, the present invention relates to silica nanoparticles comprising multi-layered silica shells with one or more bioactive ingredients encapsulated within and their applications in drug delivery; and processes of preparing the same.
    Type: Grant
    Filed: August 18, 2017
    Date of Patent: August 4, 2020
    Assignee: NATIONAL TAIWAN UNIVERSITY
    Inventors: Chung-Yuan Mou, Nai-Yuan Kou, Si-Han Wu, Yi-Ping Chen
  • Patent number: 10729747
    Abstract: The present invention discloses methods and compositions for treating or ameliorating a condition associated with increased or decreased myofibroblast activities and use thereof.
    Type: Grant
    Filed: May 7, 2019
    Date of Patent: August 4, 2020
    Assignee: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: B. Chia Soo, Kang Ting, Zhong Zheng
  • Patent number: 10729130
    Abstract: There is disclosed method of killing nematodes comprising the step of applying an effective amount of a nematicidal composition comprising a terpene component and compositions suitable for use in the method. The terpene component is preferably in association with water, either as a solution or a suspension. An excipient may also be included, which is suitably hollow glucan particles which encapsulate the terpene component.
    Type: Grant
    Filed: May 28, 2018
    Date of Patent: August 4, 2020
    Assignee: Eden Research PLC
    Inventors: Lanny Franklin, Gary Ostroff
  • Patent number: 10721907
    Abstract: The present invention includes multifunctional compositions, methods and binding systems to provide disinfecting and deodorizing coatings for hard and soft surfaces, inorganic and organic solid surfaces and particulate media and other related substrates, including human and animal skin and skin lesions; to provide neutralizing functions for malodors generated by both human, animal and industrial fluids and solid wastes; and to provide neutralizing and degrading functions for nuisance and noxious chemicals. The present invention provides compositions and methods for producing disinfecting, oxidizing and enzyme-inhibiting fluids enabling preparation of durable, stable biocidal and deodorizing coatings and media which can be widely used for biological agent control, prevention and elimination of odors, and degradation of noxious agents susceptible to chemical oxidation, and which take forms that are inoffensive to users and offer high convenience.
    Type: Grant
    Filed: July 24, 2018
    Date of Patent: July 28, 2020
    Assignee: OXISCIENCE, LLC
    Inventors: Zhengbing Cao, Xinbo Sun, Simon Johnston, Jeffrey F. Williams
  • Patent number: 10716876
    Abstract: A method of generating a collagen fiber is disclosed. Fibers generated thereby are also disclosed as well as scaffolds comprising such fibers.
    Type: Grant
    Filed: January 11, 2018
    Date of Patent: July 21, 2020
    Assignee: CollPlant Ltd.
    Inventors: Oded Shoseyov, Amit Yaari
  • Patent number: 10694917
    Abstract: Fibrous structures containing one or more particles, and methods for making same are provided.
    Type: Grant
    Filed: February 27, 2015
    Date of Patent: June 30, 2020
    Assignee: The Procter & Gamble Company
    Inventors: Andreas Josef Dreher, Mark Robert Sivik, Alyssandra Hope Hamad-Ebrahimpour, Gregory Charles Gordon, Brian Patrick Croll, Paul Dennis Trokhan, Paul Thomas Weisman
  • Patent number: 10695287
    Abstract: A topical medication including a therapeutically effective amount of an AMPK (adenosine monophosphate-activated protein kinase) agonist for use in the treatment of one or more the human or animal medical conditions. The medical conditions include, but are not limited to: shingles (herpes zoster), post-herpetic neuralgia (PHN), gout, migraine, trigeminal neuralgia, Complex Regional Pain Syndrome (CRPS), diabetic neuropathy, peripheral neuropathy, rheumatoid arthritis, insect-related wheals, urushiol-related rash, psoriasis, herpes simplex, atopic dermatitis (eczema), contact dermatitis, allergic dermatitis, neurotrophic ulcers, first- and second-degree burns (e.g., sunburn and chemical), fibromyalgia, rubeola, and acne. Also disclosed are a method of employing the composition and a wound dressing incorporating a therapeutically effective amount of an AMPK agonist in combination with an antimicrobial agent.
    Type: Grant
    Filed: August 31, 2018
    Date of Patent: June 30, 2020
    Assignee: CerSci Therapeutics, Inc.
    Inventors: Dennis I. Robbins, David H. Hitt, II
  • Patent number: 10688067
    Abstract: The present disclosure provides a sterilized chlorhexidine product for topical disinfection. The product includes a sterilized chlorhexidine gluconate composition, an applicator for facilitating application of the sterilized chlorhexidine composition, and a barrier configured to be compromised to impregnate the applicator with the sterilized chlorhexidine gluconate composition. The sterilized chlorhexidine gluconate composition includes chlorhexidine gluconate and alcohol.
    Type: Grant
    Filed: August 30, 2019
    Date of Patent: June 23, 2020
    Assignee: Sage Products, LLC
    Inventors: Jennifer M. Allen, Christopher J. Grannis, Syed M. Hasan, Timothy P. Manthei, Niles R. Manwill
  • Patent number: 10682303
    Abstract: The present invention relates to a cosmetic composition comprising (i) at least one mineral wax in a content ranging from 12% to 40% by weight relative to the total weight of the composition, (ii) at least one fatty acid, (iii) at least one mineral oil, (iv) at least one surfactant, (v) at least one ester of fatty acid and/or of fatty alcohol and (vi) at least one fixing polymer.
    Type: Grant
    Filed: June 17, 2014
    Date of Patent: June 16, 2020
    Assignee: L'OREAL
    Inventors: Thomas Fondin, Franck Clement
  • Patent number: 10675334
    Abstract: The present invention relates to a gel having a three dimensional matrix structure and a drug in the form of a solid contained within the three dimensional matrix. Gels of the invention are preferably for implantation into a patient. Storing the drug as a solid within the gel means that the drug density is high in those areas of the gel which contain solid drug. The high drug density means that a larger amount of drug can be stored in a gel of a given size relative to the amount of drug that can be stored as individual molecules. The large deposit of solid drug means that the gel can sustain release of the drug for an extended period of time. This is advantageous because it minimises the frequency of replacement or replenishment of the implanted gel, thereby minimising discomfort and inconvenience to the patient.
    Type: Grant
    Filed: February 12, 2016
    Date of Patent: June 9, 2020
    Assignee: De Montfort University
    Inventor: Margaret Joan Taylor
  • Patent number: 10675237
    Abstract: The present invention relates to a cosmetic comprising an acrylonitrile-butadiene rubber (NBR) as a carrier of a cosmetic composition and, specifically, to a cosmetic comprising a foam carrier and a cosmetic composition loaded on the foam carrier, wherein the foam carrier contains an NBR, includes pores with an average size of 200-900 ?m, and has a thickness of 1-50 mm, and wherein the cosmetic composition has a viscosity of 2,000-60,000 cps. The present invention has excellent filling ability, loading ability, and discharging ability with respect to the liquid-phase cosmetic composition, and thus facilitates carrying a liquid-phase cosmetic composition with low viscosity to high viscosity.
    Type: Grant
    Filed: August 22, 2018
    Date of Patent: June 9, 2020
    Assignee: AMOREPACIFIC CORPORATION
    Inventors: Jung Sun Choi, Kyung Ho Choi
  • Patent number: 10653718
    Abstract: The invention relates to a specific composition for oral administration of magnesium, for use in the treatment of type 2 diabetes or the complications thereof, in association with a composition for treating type 2 diabetes or the complications thereof.
    Type: Grant
    Filed: June 3, 2014
    Date of Patent: May 19, 2020
    Inventor: Fabienne Joanny Menvielle-Bourg